REFERENCES
1. Zárate A. Gregorio Marañon, un pionero de la endocrinología, cumple 50 años de su fallecimiento. Gaceta médica de México 2011;147:176-9.
2. Szent-Györgyi A. Bioenergetics. New York: Academic Press; 1957.
3. Jameson JL, Longo DL. Precision medicine--personalized, problematic, and promising. N Engl J Med 2015;372:2229-34.
4. Danziger L, Elmergreen GL. The thyroid-pituitary homeostatic mechanism. Bull Math Biophys 1956;18:1-13.
5. Bekkering GE, Agoritsas T, Lytvyn L, Heen AF, Feller M, et al. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ 2019;365:l2006.
6. Taylor P, Bianco AC. Urgent need for further research in subclinical hypothyroidism. Nat Rev Endocrinol 2019;15:503-4.
7. Moncayo R, Moncayo H. Advanced 3D sonography of the thyroid: focus on vascularity. Sonography. Rijeka, Croatia: Intech; 2012. pp. 273-92.
8. Moncayo R, Moncayo H. Applying a systems approach to thyroid physiology: looking at the whole with a mitochondrial perspective instead of just TSH values or why we should know more about mitochondria to understand metabolism. BBA Clin 2017;7:127-40.
9. Moncayo R, Moncayo H. The WOMED model of benign thyroid disease: acquired magnesium deficiency due to physical and psychological stressors relates to dysfunction of oxidative phosphorylation. BBA Clin 2015;3:44-64.
10. Moncayo R, Moncayo H. Proof of concept of the WOMED model of benign thyroid disease: Restitution of thyroid morphology after correction of physical and psychological stressors and magnesium supplementation. BBA Clin 2015;3:113-22.
11. Riedel BM. Die chronische, zur Bildung eisenharter Tumoren führende Entzündung der Schilddrüse. Verh Dtsch Ges Chir 1896;25:101-5.
12. de Quervain F. Ueber acute, nicht eiterige Thyroiditis. Arch f klin Chir 1902;67:706-14.
13. McCarrison R. Observations on endemic cretinism in the chitral and gilgit valleys. Ind Med Gaz 1908;43:441-9.
14. Hashimoto H. Zur Kenntniss der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch Klin Chir 1912;97:219-48.
15. Graham A, McCullagh EP. Atrophy and fibrosis associated with lymphoid tissue in the thyroid - Struma lymphomatosa (Hashimoto). Arch Surg 1931;22:548-67.
16. Graham A. Riedel’s struma in contrast to struma lymphomatosa. West J Surg 1931;39:681-92.
17. Eisen D. The Relationship between Riedel’s Struma and Struma Lymphomatosa (Hashimoto). Can Med Assoc J 1934;31:147-50.
18. Clute HM, Eckerson EB, Warren S. Clinical aspects of struma lymphomatosa (Hashimoto). Arch Surg 1935;31:419-28.
19. McClintock JC, Wright AW. Riedel’s struma and struma lymphomatosa (Hashimoto): a comparative study. Ann Surg 1937;106:11-32.
21. Lundbæk K. On chronic Thyroiditis, Riedel’s Struma, »Hashimoto’s Struma», and Lymphadenoid goiter, with Report of a Case of Chronic Thyroiditis. Acta Medica Scandinavica 1942;112:55-67.
22. Simmonds M. Über chronische Thyreoiditis und fibröse Atrophie der Thyreoidea. Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin 1923;246:140-50.
24. Statland H, Wasserman MM, Vickery AL. Struma lymphomatosa (Hashimoto’s struma); review of fifty-one cases with a discussion of the endocrinologic aspects. AMA Arch Intern Med 1951;88:659-78.
25. Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW. Chronic thyroiditis and autoimmunisation. JAMA 1957;164:1439-47.
26. Roitt IM, Doniach D, Campbell PN, Hudson RV. Auto-antibodies in Hashimoto’s disease (lymphadenoid goitre). Lancet 1956;271:820-1.
27. Doniach D, Roitt IM. Autoimmunity in Hashimoto’s disease and its implications. J Clin Endocrinol Metab 1957;27:1293-304.
28. Burek CL. Autoimmune thyroiditis research at Johns Hopkins University. Immunol Res 2010;47:207-15.
30. Katz SM, Vickery AL Jr. The fibrous variant of Hashimoto’s thyroiditis. Hum Pathol 1974;5:161-70.
31. McCarrison R. Note on the experimental production of lymphadenoid goitre in rats. Br Med J 1929;1:5-6.
32. Freund J, Casals J, Page Hosmer E. Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil. Exp Biol Med 1937;37:509-13.
33. Shulman S, Rose NR, Witebsky E. Studies on organ specificity. III. Ultracentrifugal and electrophoretic examinations of thyroid extracts. J Immunol 1955;75:291-300.
34. Weigle WO. The induction of autoimmunity in rabbits following injection of heterologous or altered homologous thyroglobulin. J Exp Med 1965;121:289-308.
37. Leo O, Cunningham A, Stern PH. Vaccine immunology. Perspect Vaccinol 2011;1:25-59.
38. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 2014;13:391-7.
39. Rose NR, Witebsky E. Studies on organ specificity. II. Serological interrelationships among thyroid extracts of various species. J Immunol 1955;75:282-90.
40. Witebsky E, Rose NR, Shulman S. Studies on organ specificity. I. The serological specificity of thyroid extracts. J Immunol 1955;75:269-81.
41. Roitt IM, Campbell PN, Doniach D. The nature of the thyroid auto-antibodies present in patients with Hashimoto’s thyroiditis (lymphadenoid goitre). Biochem J 1958;69:248-56.
42. Ritossa F. A new puffing pattern induced by temperature shock and DNP in drosophila. Experientia 1962;18:571-3.
43. Wartenberg J, Doniach D, Brostoff J, Roitt IM. Leucocyte migration inhibition with mitochondria in human autoimmune thyroid disorders. Clin Exp Immunol 1973;14:203-12.
44. White GH, Walmsley RN. Plasma enzyme activities in primary hypothyroidism. Clin Chem 1984;30:323-5.
45. Medeiros-Neto G, Kim PS, Yoo SE, Vono J, Targovnik HM, et al. Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest 1996;98:2838-44.
47. Zimmermann FA, Neureiter D, Feichtinger RG, Trost A, Sperl W, et al. Deficiency of respiratory chain complex I in Hashimoto thyroiditis. Mitochondrion 2016;26:1-6.
48. Grootjans J, Kaser A, Kaufman RJ, Blumberg RS. The unfolded protein response in immunity and inflammation. Nat Rev Immunol 2016;16:469-84.
49. Barić A, Brčić L, Gračan S, Škrabić V, Brekalo M, et al. Thyroglobulin antibodies are associated with symptom burden in patients with Hashimoto’s thyroiditis: a cross-sectional study. Immunol Invest 2019;48:1-12.
50. Wang K, Wei H, Zhang W, Li Z, Ding L, et al. Severely low serum magnesium is associated with increased risks of positive anti-thyroglobulin antibody and hypothyroidism: a cross-sectional study. Sci Rep 2018;8:9904.
51. Hu X, Go YM, Jones DP. Omics integration for mitochondria systems biology. Antioxid Redox Signal 2020;32:853-72.
53. van Zuuren EJ, Albusta AY, Fedorowicz Z, Carter B, Pijl H. Selenium supplementation for Hashimoto’s thyroiditis. Cochrane Database Syst Rev 2013:CD010223.
54. Turker O, Kumanlioglu K, Karapolat I, Dogan I. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J Endocrinol 2006;190:151-6.
55. Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007;92:1263-8.
56. Karanikas G, Schuetz M, Kontur S, Duan H, Kommata S, et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid 2008;18:7-12.
57. Krysiak R, Okopien B. The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J Clin Endocrinol Metab 2011;96:2206-15.
58. Cochrane AL. Effectiveness and efficiency: random reflections on health services. Nuffield: Nuffield Provincial Hospitals Trust; 1972.
59. Winther KH, Bonnema SJ, Cold F, Debrabant B, Nybo M, et al. Does selenium supplementation affect thyroid function? Results from a randomized, controlled, double-blinded trial in a Danish population. Eur J Endocrinol 2015;172:657-67.
60. Hegedüs L, Bonnema SJ, Winther KH. Selenium in the treatment of thyroid diseases: an element in search of the relevant indications? Eur Thyroid J 2016;5:149-51.
61. Negro R, Attanasio R, Grimaldi F, Marcocci C, Guglielmi R, et al. A 2016 Italian survey about the clinical use of selenium in thyroid disease. Eur Thyroid J 2016;5:164-70.
62. Winther KH, Wichman JE, Bonnema SJ, Hegedüs L. Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis. Endocrine 2017;55:376-85.
63. Wu Q, Rayman MP, Lv H, Schomburg L, Cui B, et al. Low population selenium status is associated with increased prevalence of thyroid disease. J Clin Endocrinol Metab 2015;100:4037-47.
64. Mao J, Pop VJ, Bath SC, Vader HL, Redman CW, et al. Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency. Eur J Nutr 2016;55:55-61.
65. Esposito D, Rotondi M, Accardo G, Vallone G, Conzo G, et al. Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial. J Endocrinol Invest 2017;40:83-9.
66. Neville LF, Mathiak G, Bagasra O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev 1997;8:207-19.
67. Luster AD, Unkeless JC, Ravetch JV. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985;315:672-6.
68. Pirola I, Rotondi M, Cristiano A, Maffezzoni F, Pasquali D, et al. Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: results of the SETI study. Endocrinol Diabetes Nutr 2020;67:28-35.
69. Rani P, Lalitha K. Evidence for altered structure and impaired mitochondrial electron transport function in selenium deficiency. Biol Trace Elem Res 1996;51:225-34.
71. Davies TF. Really significant genes for autoimmune thyroid disease do not exist—so how can we predict disease? Thyroid 2007;17:1027-9.
72. Marinò M, Latrofa F, Menconi F, Chiovato L, Vitti P. Role of genetic and non-genetic factors in the etiology of Graves’ disease. J Endocrinol Invest 2015;38:283-94.
73. Struja T, Eckart A, Kutz A, Huber A, Neyer P, et al. Metabolomics for prediction of relapse in Graves’ disease: observational pilot study. Front Endocrinol (Lausanne) 2018;9:623.
74. Struja T, Eckart A, Kutz A, Neyer P, Kraenzlin M, et al. Metabolomics and their ability to distinguish thyroid disorders: a retrospective pilot study. Horm Metab Res 2019;51:256-60.
75. Galofré JC, Díez JJ, Cooper DS. Thyroid dysfunction in the era of precision medicine. Endocrinología y Nutrición (English Edition) 2016;63:354-63.
76. Ladenson PW. Precision medicine comes to thyroidology. J Clin Endocrinol Metab 2016;101:799-803.
77. Caputo M, Rivolta CM, Mories T, Corrales JJ, Galindo P, et al. Analysis of thyroglobulin gene polymorphisms in patients with autoimmune thyroiditis. Endocrine 2010;37:389-95.
78. Lo MS, Towne M, VanNoy GE, Brownstein CA, Lane AA, et al. Monogenic hashimoto thyroiditis associated with a variant in the thyroglobulin (TG) gene. J Autoimmun 2018;86:116-9.
79. Mizuma T, Watanabe M, Inoue N, Arakawa Y, Tomari S, et al. Association of the polymorphisms in the gene encoding thyroglobulin with the development and prognosis of autoimmune thyroid disease. Autoimmunity 2017;50:386-92.
80. Xuan M, Zhao SX, Yan CY, Yang J, Li Y, et al. Fine mapping of thyroglobulin gene identifies two independent risk loci for Graves’ disease in Chinese Han population. Ann Transl Med 2019;7:434.
81. Vono-Toniolo J, Rivolta CM, Targovnik HM, Medeiros-Neto G, Kopp P. Naturally occurring mutations in the thyroglobulin gene. Thyroid 2005;15:1021-33.
82. Oikonomou C, Hendershot LM. Disposing of misfolded ER proteins: a troubled substrate’s way out of the ER. Mol Cell Endocrinol 2019;500:110630.
84. Depaoli MR, Hay JC, Graier WF, Malli R. The enigmatic ATP supply of the endoplasmic reticulum. Biol Rev Camb Philos Soc 2019;94:610-28.
85. Baryshev M, Sargsyan E, Wallin G, Lejnieks A, Furudate S, et al. Unfolded protein response is involved in the pathology of human congenital hypothyroid goiter and rat non-goitrous congenital hypothyroidism. J Mol Endocrinol 2004;32:903-20.
86. Baryshev M, Sargsyan E, Mkrtchian S. ERp29 is an essential endoplasmic reticulum factor regulating secretion of thyroglobulin. Biochem Biophys Res Commun 2006;340:617-24.
87. Sargsyan E, Baryshev M, Szekely L, Sharipo A, Mkrtchian S. Identification of ERp29, an endoplasmic reticulum lumenal protein, as a new member of the thyroglobulin folding complex. J Biol Chem 2002;277:17009-15.
88. Pardo V, Vono-Toniolo J, Rubio IG, Knobel M, Possato RF, et al. The p.A2215D thyroglobulin gene mutation leads to deficient synthesis and secretion of the mutated protein and congenital hypothyroidism with wide phenotype variation. J Clin Endocrinol Metab 2009;94:2938-44.
89. Zheng L, Dou X, Song H, Wang P, Qu W, et al. Bioinformatics analysis of key genes and pathways in Hashimoto thyroiditis tissues. Biosci Rep 2020;40.
90. Kotkowska A, Sewerynek E, Domańska D, Pastuszak-Lewandoska D, Brzeziańska E. Single nucleotide polymorphisms in the STAT3 gene influence AITD susceptibility, thyroid autoantibody levels, and IL6 and IL17 secretion. Cell Mol Biol Lett 2015;20:88-101.
91. Xiao L, Muhali FS, Cai TT, Song RH, Hu R, et al. Association of single-nucleotide polymorphisms in the STAT3 gene with autoimmune thyroid disease in Chinese individuals. Funct Integr Genomics 2013;13:455-61.
92. Page G, Lödige I, Kögel D, Scheidtmann KH. AATF, a novel transcription factor that interacts with Dlk/ZIP kinase and interferes with apoptosis. FEBS Lett 1999;462:187-91.
93. Brčić L, Barić A, Benzon B, Brekalo M, Gračan S, et al. AATF and SMARCA2 are associated with thyroid volume in Hashimoto’s thyroiditis patients. Sci Rep 2020;10:1754.
94. Ishigaki S, Fonseca SG, Oslowski CM, Jurczyk A, Shearstone JR, et al. AATF mediates an antiapoptotic effect of the unfolded protein response through transcriptional regulation of AKT1. Cell Death Differ 2010;17:774-86.
95. Stillman JH. Heat Waves, the new normal: summertime temperature extremes will impact animals, ecosystems, and human communities. Physiology (Bethesda) 2019;34:86-100.
96. Ercan MT, Aras T, Unlenen E, Unlü M, Unsal IS, et al. 99mTc-citrate versus 67Ga-citrate for the scintigraphic visualization of inflammatory lesions. Nucl Med Biol 1993;20:881-7.
98. Sulman FG, Tal E, Pfeifer Y, Superstine E. Intermittent hyperthyreosis -- a heat stress syndrome. Horm Metab Res 1975;7:424-8.
99. Kikusato M, Nakamura K, Mikami Y, Mujahid A, Toyomizu M. The suppressive effect of dietary coenzyme Q10 on mitochondrial reactive oxygen species production and oxidative stress in chickens exposed to heat stress. Anim Sci J 2016;87:1244-51.
100. Schniertshauer D, Muller S, Mayr T, Sonntag T, Gebhard D, et al. Accelerated regeneration of ATP level after irradiation in human skin fibroblasts by Coenzyme Q10. Photochem Photobiol 2016;92:488-94.
101. Trautinger F. Heat shock proteins in the photobiology of human skin. J Photochem Photobiol B 2001;63:70-7.
102. Adair FW. Inhibition of oxygen utilization and destruction of ubiquinone by ultraviolet irradiation of Thiobacillus thiooxidans. J Bacteriol 1968;95:147-51.
103. Anderson CM, Kazantzis M, Wang J, Venkatraman S, Goncalves RL, et al. Dependence of brown adipose tissue function on CD36-mediated coenzyme Q uptake. Cell Rep 2015;10:505-15.
104. Bendahan D, Desnuelle C, Vanuxem D, Confort-Gouny S, Figarella-Branger D, et al. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 1992;42:1203-8.
106. Heidelberger M, Palmer WW. The preparation and properties of thyroglobulin. J Biol Chem 1933;101:433-9.
108. Heidelberger M, Pedersen KO. The molecular weight and isoelectric point of thyroglobulin. J Gen Physiol 1935;19:95-108.
109. Derrien Y, Michel R, Roche J. Recherches sur la preparation et les proprietes de la thyroglobulin pure I. Biochimica Et Biophysica Acta 1948;2:454-70.
110. Witebsky E, Rose NR, Shulman S. The autoantibody nature of the thyroiditis antibody and the role of thyroglobulin in the reaction. Lancet 1958;1:808-10.
111. Cheng HF, Peterson RE, Evans TC. Preparation of highly purified human thyroglobulin. Biochim Biophys Acta 1968;168:161-4.
112. Druetta L, Croizet K, Bornet H, Rousset B. Analyses of the molecular forms of serum thyroglobulin from patients with Graves’ disease, subacute thyroiditis or differentiated thyroid cancer by velocity sedimentation on sucrose gradient and Western blot. Eur J Endocrinol 1998;139:498-507.
113. Sellitti DF, Suzuki K. Intrinsic regulation of thyroid function by thyroglobulin. Thyroid 2014;24:625-38.
114. Gérard AC, Denef JF, Colin IM, van den Hove MF. Evidence for processing of compact insoluble thyroglobulin globules in relation with follicular cell functional activity in the human and the mouse thyroid. Eur J Endocrinol 2004;150:73-80.
115. Smeds S, Anderberg B. Depletion of colloid 27S and larger thyroid iodoproteins following treatment with propylthiouracil. Acta Endocrinol (Copenh) 1979;91:644-9.
116. Smeds S. On the distribution of thyroglobin and larger iodoproteins in single rat thyroid follicles. Pflugers Arch 1977;372:145-8.
117. Kim PS, Bole D, Arvan P. Transient aggregation of nascent thyroglobulin in the endoplasmic reticulum: relationship to the molecular chaperone, BiP. J Cell Biol 1992;118:541-9.
118. Christis C, Fullaondo A, Schildknegt D, Mkrtchian S, Heck AJ, et al. Regulated increase in folding capacity prevents unfolded protein stress in the ER. J Cell Sci 2010;123:787-94.
119. Adkison LR, Taylor S, Beamer WG. Mutant gene-induced disorders of structure, function and thyroglobulin synthesis in congenital goitre (cog/cog) in mice. J Endocrinol 1990;126:51-8.
120. Kim PS, Kwon OY, Arvan P. An endoplasmic reticulum storage disease causing congenital goiter with hypothyroidism. J Cell Biol 1996;133:517-27.
121. Kozutsumi Y, Segal M, Normington K, Gething MJ, Sambrook J. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 1988;332:462-4.
122. Shiu RP, Pouyssegur J, Pastan I. Glucose depletion accounts for the induction of two transformation-sensitive membrane proteinsin Rous sarcoma virus-transformed chick embryo fibroblasts. Proc Natl Acad Sci U S A 1977;74:3840-4.
123. Lee AS. The accumulation of three specific proteins related to glucose-regulated proteins in a temperature-sensitive hamster mutant cell line K12. J Cell Physiol 1981;106:119-25.
125. Ordookhani A, Mirmiran P, Walfish PG, Azizi F. Transient neonatal hypothyroidism is associated with elevated serum anti-thyroglobulin antibody levels in newborns and their mothers. J Pediatr 2007;150:315-7. 7e2
126. Cho EM, Kim UH, Choi BH, Ko CW. Changes of antithroglobulin antibody in children with congenital hypothyroidism. Ann Pediatr Endocrinol Metab 2013;18:179-82.
127. Peteiro-Gonzalez D, Lee J, Rodriguez-Fontan J, Castro-Piedras I, Cameselle-Teijeiro J, et al. New insights into thyroglobulin pathophysiology revealed by the study of a family with congenital goiter. J Clin Endocrinol Metab 2010;95:3522-6.
128. Nicholas AK, Serra EG, Cangul H, Alyaarubi S, Ullah I, et al. Comprehensive screening of eight known causative genes in congenital hypothyroidism with gland-in-situ. J Clin Endocrinol Metab 2016;101:4521-31.
129. Citterio CE, Siffo S, Moya CM, Pio MG, Molina MF, et al. p.L571P in the linker domain of rat thyroglobulin causes intracellular retention. Mol Cell Endocrinol 2020;505:110719.
130. Citterio CE, Targovnik HM, Arvan P. The role of thyroglobulin in thyroid hormonogenesis. Nat Rev Endocrinol 2019;15:323-38.
131. Bernard C. Leçons sur les phénomenes de la vie communs aux animaux et aux végétaux. Paris: JB Bailliere et fils; 1878.
133. Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science 2008;319:916-9.
134. Kotas ME, Medzhitov R. Homeostasis, inflammation, and disease susceptibility. Cell 2015;160:816-27.
136. Targovnik HM, Scheps KG, Rivolta CM. Defects in protein folding in congenital hypothyroidism. Mol Cell Endocrinol 2020;501:110638.
137. Clairmont CA, De Maio A, Hirschberg CB. Translocation of ATP into the lumen of rough endoplasmic reticulum-derived vesicles and its binding to luminal proteins including BiP (GRP 78) and GRP 94. J Biol Chem 1992;267:3983-90.
138. Peth A, Uchiki T, Goldberg AL. ATP-dependent steps in the binding of ubiquitin conjugates to the 26S proteasome that commit to degradation. Mol Cell 2010;40:671-81.
139. Tsvetkov P, Myers N, Eliav R, Adamovich Y, Hagai T, et al. NADH binds and stabilizes the 26S proteasomes independent of ATP. J Biol Chem 2014;289:11272-81.
141. Patel A, Malinovska L, Saha S, Wang J, Alberti S, et al. ATP as a biological hydrotrope. Science 2017;356:753-6.
142. Zhuang ZX, Chen SE, Chen CF, Lin EC, Huang SY. Genome-wide association study on the body temperature changes of a broiler-type strain Taiwan country chickens under acute heat stress. J Therm Biol 2019;82:33-42.
143. Grases G, Pérez-Castelló JA, Sanchis P, Casero A, Perelló J, et al. Anxiety and stress among science students. Study of calcium and magnesium alterations. Magnes Res 2006;19:102-6.
144. Boreková M, Hojerová J, Koprda V, Bauerová K. Nourishing and health benefits of coenzyme Q10. Czech J Food Sci 2008;26:229-41.
145. Hsu JM, Root AW, Duckett GE, Smith JC Jr, Yunice AA, et al. The effect of magnesium depletion on thyroid function in rats. J Nutr 1984;114:1510-7.
146. Xu J, Tang S, Song E, Yin B, Wu D, et al. Hsp70 expression induced by Co-Enzyme Q10 protected chicken myocardial cells from damage and apoptosis under in vitro heat stress. Poult Sci 2017;96:1426-37.
147. Xu J, Yin B, Huang B, Tang S, Zhang X, et al. Co-enzyme Q10 protects chicken hearts from in vivo heat stress via inducing HSF1 binding activity and Hsp70 expression. Poult Sci 2019;98:1002-11.
148. Xu J, Tang S, Yin B, Sun J, Song E, et al. Co-enzyme Q10 and acetyl salicylic acid enhance Hsp70 expression in primary chicken myocardial cells to protect the cells during heat stress. Mol Cell Biochem 2017;435:73-86.
149. Nagashima Y, Iwata Y, Ashida M, Mishiba K, Koizumi N. Exogenous salicylic acid activates two signaling arms of the unfolded protein response in Arabidopsis. Plant Cell Physiol 2014;55:1772-8.
150. Poór P, Czékus Z, Tari I, Ördög A. The multifaceted roles of plant hormone salicylic acid in endoplasmic reticulum stress and unfolded protein response. Int J Mol Sci 2019;20.
151. Poór P. Effects of salicylic acid on the metabolism of mitochondrial reactive oxygen species in plants. Biomolecules 2020;10.
152. Gerschman R, Gilbert DL, Nye SW, Dwyer P, Fenn WO. Oxygen poisoning and x-irradiation: a mechanism in common. Science 1954;119:623-6.
153. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.
154. Adam-Vizi V, Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 2006;27:639-45.
155. Kalén A, Appelkvist EL, Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids 1989;24:579-84.
156. Green J, Edwin EE, Diplock AT, Bunyan J. Role of selenium in relation to ubiquinone in the rat. Nature 1961;189:748-9.
157. Hidiroglou M, Jenkins K, Carson RB, Brossard GA. Selenium and coenzyme Q10 levels in the tissues of dystrophic and healthy calves. Can J Physiol Pharmacol 1967;45:568-9.
158. Vadhanavikit S, Ganther HE. Decreased ubiquinone levels in tissues of rats deficient in selenium. Biochem Biophys Res Commun 1993;190:921-6.
159. Vadhanavikit S, Ganther HE. Selenium deficiency and decreased coenzyme Q levels. Mol Aspects Med 1994;15 Suppl:s103-7.
160. Xing L, Chen C, Li B, Yu H, Chai ZF. Distribution and location of selenium and other elements in different mitochondrial compartments of human liver by neutron activation analysis. J Radioanal Nucl Chem 2006;269:527-34.
161. Lee JH, Park KJ, Jang JK, Jeon YH, Ko KY, et al. Selenoprotein S-dependent Selenoprotein K binding to p97(VCP) protein is essential for endoplasmic reticulum-associated degradation. J Biol Chem 2015;290:29941-52.
162. Ren B, Liu M, Ni J, Tian J. Role of selenoprotein F in protein folding and secretion: potential involvement in human disease. Nutrients 2018;10.
163. Labunskyy VM, Yoo MH, Hatfield DL, Gladyshev VN. Sep15, a thioredoxin-like selenoprotein, is involved in the unfolded protein response and differentially regulated by adaptive and acute ER stresses. Biochemistry 2009;48:8458-65.
164. Hamieh A, Cartier D, Abid H, Calas A, Burel C, et al. Selenoprotein T is a novel OST subunit that regulates UPR signaling and hormone secretion. EMBO Rep 2017;18:1935-46.
165. Addinsall AB, Wright CR, Andrikopoulos S, van der Poel C, Stupka N. Emerging roles of endoplasmic reticulum-resident selenoproteins in the regulation of cellular stress responses and the implications for metabolic disease. Biochem J 2018;475:1037-57.
166. Ha HY, Alfulaij N, Berry MJ, Seale LA. From selenium absorption to selenoprotein degradation. Biol Trace Elem Res 2019;192:26-37.
167. Pitts MW, Hoffmann PR. Endoplasmic reticulum-resident selenoproteins as regulators of calcium signaling and homeostasis. Cell Calcium 2018;70:76-86.
168. Rocca C, Pasqua T, Boukhzar L, Anouar Y, Angelone T. Progress in the emerging role of selenoproteins in cardiovascular disease: focus on endoplasmic reticulum-resident selenoproteins. Cell Mol Life Sci 2019;76:3969-85.
169. Anouar Y, Lihrmann I, Falluel-Morel A, Boukhzar L. Selenoprotein T is a key player in ER proteostasis, endocrine homeostasis and neuroprotection. Free Radic Biol Med 2018;127:145-52.
170. Lange H, Kaut A, Kispal G, Lill R. A mitochondrial ferredoxin is essential for biogenesis of cellular iron-sulfur proteins. Proc Natl Acad Sci U S A 2000;97:1050-5.
171. Sipos K, Lange H, Fekete Z, Ullmann P, Lill R, et al. Maturation of cytosolic iron-sulfur proteins requires glutathione. J Biol Chem 2002;277:26944-9.
172. Cai K, Frederick RO, Kim JH, Reinen NM, Tonelli M, et al. Human mitochondrial chaperone (mtHSP70) and cysteine desulfurase (NFS1) bind preferentially to the disordered conformation, whereas co-chaperone (HSC20) binds to the structured conformation of the iron-sulfur cluster scaffold protein (ISCU). J Biol Chem 2013;288:28755-70.
173. Fuss JO, Tsai CL, Ishida JP, Tainer JA. Emerging critical roles of Fe-S clusters in DNA replication and repair. Biochim Biophys Acta 2015;1853:1253-71.
174. Ayaub EA, Tandon K, Padwal M, Imani J, Patel H, et al. IL-6 mediates ER expansion during hyperpolarization of alternatively activated macrophages. Immunol Cell Biol 2019;97:203-17.
175. Stehling O, Paul VD, Bergmann J, Basu S, Lill R. Biochemical analyses of human iron-sulfur protein biogenesis and of related diseases. Methods Enzymol 2018;599:227-63.
176. Vigani G, Pii Y, Celletti S, Maver M, Mimmo T, et al. Mitochondria dysfunctions under Fe and S deficiency: is citric acid involved in the regulation of adaptive responses? Plant Physiol Biochem 2018;126:86-96.
177. Burschel S, Kreuzer Decovic D, Nuber F, Stiller M, Hofmann M, et al. Iron-sulfur cluster carrier proteins involved in the assembly of Escherichia coli NADH:ubiquinone oxidoreductase (complex I). Mol Microbiol 2019;111:31-45.
178. Tsaousis AD. On the origin of iron/sulfur cluster biosynthesis in eukaryotes. Front Microbiol 2019;10:2478.
179. Desbats MA, Vetro A, Limongelli I, Lunardi G, Casarin A, et al. Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure. Eur J Hum Genet 2015;23:1254-8.
180. O’Connor J, Bensky D. Acupuncture. A comprehensive text. Shanghai College of Traditional Medicine. Seattle: Eastland Press; 1982.
181. Porkert M, Ullmann C. Chinese Medicine. New York: Henry Holt; 1982.
182. Kaptchuk TJ. The web that has no weaver: understanding chinese medicine. New York: Congdon & Weed; 1983.
183. Matsumoto K, Birch S. Extraordinary vessels. Brookline: Paradigm Publications; 1986.
184. Ellis A, Wiseman N, Boss K. Grasping the wind. Brookline: Paradigm Publications; 1989.
185. Flaws B. Sticking to the point. Boulder: Blue Poppy Press; 1990.
186. Ross J. Acupuncture point combinations: The Key to Clinical Success: Churchill Livingstone; 1995.
187. Kirschbaum B. Die 8 außerordentlichen Gefäße in der traditionellen chinesischen Medizin. Uelzen: Medizinisch Literarische Verlagsgesellschaft mbH; 2000.
188. Deadman P, Al-Khafaji M, Baker K. A manual of acupuncture. Hove: Journal of Chinese Medicine Publications; 2001.
189. Hicks A, Hicks J, Mole P. Five element constitutional acupuncture. Edinburgh: Churchill Livingstone; 2004.
190. Maciocia G. The foundations of chinese medicine. a comprehensive text for acupuncturists and herbalists. Oxford: Elsevier; 2005.
191. Maciocia G. The channels of acupuncture: clinical use of the secondary channels and eight extraordinary vessels. Churchill Livinstone; 2006.
192. Smith RL, Soeters MR, Wust RCI, Houtkooper RH. Metabolic Flexibility as an adaptation to energy resources and requirements in health and disease. Endocr Rev 2018;39:489-517.
193. Morishita Y, Kabil O, Young KZ, Kellogg AP, Chang A, et al. Thyrocyte cell survival and adaptation to chronic endoplasmic reticulum stress due to misfolded thyroglobulin. J Biol Chem 2020; doi: 10.1074/jbc.RA120.012656.
194. Moncayo R, Moncayo H. Exploring the aspect of psychosomatics in hypothyroidism: the WOMED model of body-mind interactions based on musculoskeletal changes, psychological stressors, and low levels of magnesium. Woman Psychosomatic Gynaecol Obstet 2014;1:1-11.
195. Santos LR, Durães C, Ziros PG, Pestana A, Esteves C, et al. Interaction of genetic variations in NFE2L2 and SELENOS modulates the risk of Hashimoto’s thyroiditis. Thyroid 2019;29:1302-15.
196. Addinsall AB, Martin SD, Collier F, Conlan XA, Foletta VC, et al. Differential regulation of cellular stress responses by the endoplasmic reticulum-resident Selenoprotein S (Seps1) in proliferating myoblasts versus myotubes. Physiol Rep 2018;6:e13926.
197. Marañon G. La sangre en los estados tiroideos. Universidad Central (Madrid); 1911.
198. Marañon G. Le facteur émotionnel dans la pathogénie des états hyperthyroïdiens. Ann de Med 1921;60:81-93.
200. Fierro-Benítez R, Penafiel W, De Groot LJ, Ramirez I. Endemic goiter and endemic cretinism in the Andean region. N Engl J Med 1969;280:296-302.
201. Kim PS, Dunn AD, Dunn JT. Altered immunoreactivity of thyroglobulin in thyroid disease. J Clin Endocrinol Metab 1988;67:161-8.
